Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mateusz Siedlinski

TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Related publications

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-Α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients

Archivum Immunologiae et Therapiae Experimentalis

English

De Subitaneis Mortibus. XXIII. Rheumatoid Arthritis and Ankylosing Spondylitis

Circulation

Cardiovascular Medicine

Physiology

Cardiology

1977

English

Application of TNF-alpha Inhibitors in Treatment of Uveitis Associated With Ankylosing Spondylitis

English

Recommendations for Starting Anti TNF-α in Patients With Ankylosing Spondylitis

Reumatismo

Rheumatology

2011

English

Utility and Direct Costs: Ankylosing Spondylitis Compared With Rheumatoid Arthritis

Annals of the Rheumatic Diseases

English

Psoriatic Spondylitis in a Patient With Classical Rheumatoid Arthritis.

Postgraduate Medical Journal

Medicine

1983

English

The Effects of CD20 Inhibitors Therapy in Comparison to TNF Α Inhibitors Therapy on IL-17 in Patients With Active Rheumatoid Arthritis .

IOSR Journal of Applied Chemistry

2013

English

Cost-Minimization Analysis of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Under the Brazilian Private Health Care System Perspective

English

TNF-alpha Antagonists for Treatment of Juvenile Ankylosing Spondylitis

Pediatric Rheumatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mateusz Siedlinski

TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis

Related publications

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-Α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients

De Subitaneis Mortibus. XXIII. Rheumatoid Arthritis and Ankylosing Spondylitis

Application of TNF-alpha Inhibitors in Treatment of Uveitis Associated With Ankylosing Spondylitis

Recommendations for Starting Anti TNF-α in Patients With Ankylosing Spondylitis

Utility and Direct Costs: Ankylosing Spondylitis Compared With Rheumatoid Arthritis

Psoriatic Spondylitis in a Patient With Classical Rheumatoid Arthritis.

The Effects of CD20 Inhibitors Therapy in Comparison to TNF Α Inhibitors Therapy on IL-17 in Patients With Active Rheumatoid Arthritis .

Cost-Minimization Analysis of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Under the Brazilian Private Health Care System Perspective

TNF-alpha Antagonists for Treatment of Juvenile Ankylosing Spondylitis